Gilad Oren bought APRE
January 30, 2026 · Form 4 insider transaction
Gilad Oren bought 28,100 shares of Aprea Therapeutics, Inc. at $0.89 per share, a transaction worth $25.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Footnotes
On January 28, 2026, the Issuer entered into a securities purchase agreement with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement, which closed on January 30, 2026, an aggregate of 28,100 shares of the Issuer's common stock (the "Shares") at a purchase price of $0.89 per Share. The Reporting Person also received accompanying common warrants (the "Common Warrants") to purchase up to an aggregate of 28,100 Shares.